Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cicatrix: early-phase trial registry
1 of 5 indexed Cicatrix trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Cicatrix: 5 US clinical trials tracked, 1 recruiting.
Cicatrix is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is The Center for Clinical and Cosmetic Research, running 1 of these trials.
Enrollment posture brief
Registry condition cicatrix
OPEN 1 | RECR 20% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Cicatrix lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cicatrix on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cicatrix is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cicatrix research.
The Center for Clinical and Cosmetic Research accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Cicatrix trials plan to enrol fewer than 100 people.
Median target enrolment is 25 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.
-
Cicatrix research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Treatment of Hypopigmented Scars With Bimatoprost
Medstar Health Research Institute
NCT06122090
Abdominal Scar Improvement in Microsurgical Breast Reconstruction
Stanford University
NCT05377723
A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars
Northwestern University
NCT01976260
"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"
The Center for Clinical and Cosmetic Research
NCT04169490
Laser Resurfacing Versus Dermabrasion for Scar Revision
University of Minnesota
NCT01176448
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Cicatrix records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cicatrix trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cicatrix page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cicatrix trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Center for Clinical and Cosmetic Research sponsors the most Cicatrix trials on record, review their full trial history before evaluating a specific study. See The Center for Clinical and Cosmetic Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cicatrix condition card totals 5 registered trials; most-linked intervention Active Comparator Silicone Gel (Kelo-Cote) + FS2 Emulsion Moisturizer; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.